Explore evidence

80 %Of 532 exit interview respondents, 80% (426/532) had been reached by the awareness campaign.

Kenyacancer du seinpublished 2022Cancer reports (Hoboken, N.J.)PubMeddocument of 17 observations

35 %A catastrophic 35% increase in the burden of breast cancer in Kenya has been predicted by 2025.

Kenyacancer du seinobserved 2025published 2019BMJ openeurope_pmc

49 monthsThe median survival time for patients receiving aromatase inhibitors was 49.0 months compared to 42.0 ± 3.6 months for those on tamoxifen among hormone receptor-positive breast cancer patients at Kenyatta National Hospital.

Kenyacancer du seinobserved 2019 to 2022published 2025Journal of the Egyptian National Cancer InstitutePubMeddocument of 6 observations

0.45 odds_ratioCompared to patients with luminal A tumors, luminal B patients had an odds ratio of 0.45 for lower parity (≥5 vs ≤2 children), with 95% confidence interval (0.23, 0.87) and p = 0.018.

Kenyacancer du seinobserved between March 2012 to May 2015published 2021Breast cancer research : BCRPubMeddocument of 9 observations

1.5 %The prevalence of late pregnancy as a breast cancer risk factor was 1.5% among the studied women.

Kenyacancer du seinobserved 2019 and 2020published 2026JCO global oncologyPubMeddocument of 10 observations

2.6 %The prevalence of personal history of breast cancer as a breast cancer risk factor was 2.6% among the studied women.

Kenyacancer du seinobserved 2019 and 2020published 2026JCO global oncologyPubMeddocument of 10 observations

8 monthsThe survival time from metastasis to death was 8 ± 0.6 months in the aromatase inhibitor group versus 6 ± 0.8 months in the tamoxifen group among hormone receptor-positive breast cancer patients at Kenyatta National Hospital.

Kenyacancer du seinobserved 2019 to 2022published 2025Journal of the Egyptian National Cancer InstitutePubMeddocument of 6 observations

27 %27% of women with breast cancer admitted to inpatient hospice in Western Kenya were discharged home.

Kenyacancer du seinobserved 2011-2019published 2022Journal of pain and symptom managementPubMeddocument of 10 observations